Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel versus clopidogrel plus aspirin in acute coronary syndrome patients undergoing PCI
2004-000023-15Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of clopidogrel in acute coronary syndrome (ACS) (2 arms), sponsored by Eli Lilly and Company. Primary endpoints: Primary composite endpoint, Primary hierarchical analysis in UA/NSTEMI and 1 more. Started Oct 2004; status: completed.
02
Drugs
clopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2004-000023-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000023-15.